Spelman T, et al. Comparative effectiveness of switching to natalizumab or fingolimod after relapse on first-line relapsing-remitting multiple sclerosis therapy: propensity score matching analysis from the MSBase registry. ECTRIMS 2018, abstract 59.
ZonMw investeert in verbeteren leefstijl na beroerte
jan 2024 | Myocardinfarct, Neuro-vasculair